Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2010-04-15 09:07 |
Swedish Orphan Biovitrum and Pharming sign Rhucin® distribution agreement
|
English | 79.1 KB | ||
| 2010-04-01 08:40 |
Pharming's C1 inhibitor effective in preventing AMR in animal model of transpla…
|
English | 72.1 KB | ||
| 2010-03-30 16:40 |
Pharming shareholders approve items on EGM agenda
|
English | 77.6 KB | ||
| 2010-03-18 16:18 |
Pharming submits response to questions MAA Rhucin
|
English | 82.5 KB | ||
| 2010-03-15 08:10 |
Pharming to hold extraordinary shareholders' meeting
|
English | 74.2 KB | ||
| 2010-02-18 08:04 |
Pharming announces 2009 results
|
English | 104.1 KB | ||
| 2010-02-17 08:21 |
Pharming's C1 inhibitor product potentially effective in reducing complications…
|
English | 74.7 KB | ||
| 2010-01-22 08:25 |
Pharming gives update on Rhucin EU Marketing Authorization Application
|
English | 77.0 KB | ||
| 2010-01-12 08:34 |
Pharming provides business update
|
English | 82.9 KB | ||
| 2010-01-05 14:55 |
Pharming obtains EURO 7.5 million financing
|
English | 69.8 KB | ||
| 2009-12-09 09:12 |
Pharming completes pre-BLA meeting with US FDA for Rhucin submission
|
English | 69.0 KB | ||
| 2009-10-27 08:31 |
PHARMING TO PRESENT AT BIO-EUROPE 2009
|
English | 68.1 KB | ||
| 2009-10-23 09:16 |
Pharming recombinant human C1 inhibitor: results in pre-clinical ischaemic repe…
|
English | 80.8 KB | ||
| 2009-10-16 08:24 |
Pharming announces third quarter 2009 results
|
English | 103.9 KB | ||
| 2009-10-16 00:00 | English | 103.9 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
